北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 临床药理研究所  > 期刊论文
学科主题: 药理学
题名:
美罗培南与泰能随机对照治疗细菌性感染临床评价
其他题名: A randomized, controlled clinical trial on meropenem versus imipenem/ cilastatin for the treatment of bacterial infections
作者: 侯芳1; 李家泰1; 吴国平1; 郑波1; 陈亦芳1; 顾俊明1; 王慧玲1; 霍丽1; 薜欣1; 贾长绪1; 尹永红1; 田晓峰1; 任双义1
关键词: 美罗培南 ; 泰能 ; 感染 ; meropenem ; imipenem/cilastatin ; infection
刊名: 中华医学杂志(英文版)
发表日期: 2002
DOI: 10.3760/j.issn:0366-6999.2002.12.019
卷: 115, 期:12, 页:1849-1854
文章类型: Journal Article
摘要: 目的评价美罗培南的安全性和有效性.方法共入选182例,其中试验组90例,疗效评价70例,不良反应评价72例;对照组92例,疗效评价70例,不良反应评价70例.组药方法为美罗培南500 mg/次,Q12 h (必要时1 g,Q12 h),静脉点滴30分钟;泰能(亚胺培南/西司他丁,500 mg/500 mg),500 mg/次,Q 12 h(必要时1 g, Q12 h),静脉点滴30分钟,疗程均为7-14天.结果两药临床有效率分别为90%与87%,细菌清除率分别为86%(55/64)和86%(57/66),76%(93/123)的临床分离致病菌进行株致病菌产β-内酰胺酶阳性.不良反应发生率分别为9.7%(7/72)与8.6%(6/70).以上结果经统计学处理无显著差异(P>0.05).结论美罗培南治疗细菌性感染(包括酶菌感染)安全有效. Objective To evaluate the efficacy and safety of meropenem in Chinese patients, we conducted a study for the treatment of patients with lower respiratory tract infections, urinary tract infections and other infections. Methods A total of 182 hospitalized patients were enrolled in the study. 90 patients received 500 mg meropenem every 12 hours (or 1 g every 12 hours if necessary) and 92 patients received imipenem/cilastatin 500 mg/500 mg every 12 hours (or 1 g every 12 hours if necessary) by intravenous infusion. The duration of treatment was 7-14 days for both groups. Results Seventy of 90 cases receiving meropenem and 70 of 92 cases receiving imipenem/cilastatin were assessable for clinical efficacy. The overall efficacy rates were 90% for the meropenem group and 87% for the imipenem/cilastatin group, and the bacterial eradication rates were 86% in both groups. 93 (76%) of 123 strains isolated from patients produced β-lactamases. Adverse drug reactions were evaluated in 72 cases in the meropenem group and 70 cases in the imipenem/cilastatin group. The adverse drug reaction rates were 9.7% and 8.6%, respectively. The results showed that there were no statistical differences between these two groups (P>0.05). Conclusion Meropenem is effective and safe for the treatment of bacterial infections caused mainly by beta-lactamase-producing strains.
语种: 中文
原文出处: 查看原文
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/44294
Appears in Collections:北京大学第一临床医学院_临床药理研究所_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.北京大学第一医院临床药理研究所,北京,100034
2.大连医科大学第二附属医院呼吸内科 大连 116023

Recommended Citation:
侯芳,李家泰,吴国平,等. 美罗培南与泰能随机对照治疗细菌性感染临床评价[J]. 中华医学杂志(英文版),2002,115(12):1849-1854.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[侯芳]'s Articles
[李家泰]'s Articles
[吴国平]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[侯芳]‘s Articles
[李家泰]‘s Articles
[吴国平]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace